CAS: 1807861-48-8
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | ONC212 REF: IN-DA01EOMRCAS: 1807861-48-8 | 98% | To inquire | Thu 27 Mar 25 |
 | ONC212 REF: TM-T7398CAS: 1807861-48-8 | ≥95% | 52.00 €~617.00 € | Thu 03 Apr 25 |
 | ONC212 REF: 3D-HXC86148CAS: 1807861-48-8 | Min. 95% | To inquire | Thu 08 May 25 |
Ref: IN-DA01EOMR
| 10mg | 104.00 € | ||
| 25mg | 137.00 € | ||
| 50mg | 164.00 € | ||
| 100mg | 261.00 € | ||
| 250mg | 587.00 € |
Estimated delivery in United States, on Thursday 27 Mar 2025
ONC212
CAS:1807861-48-8
ONC212, a fluorinated-ONC201 analogue, is a selective agonist of GPR132.
Formula:
C24H23F3N4O
Purity:
≥95%
Color and Shape:
Solid
Molecular weight:
440.46
Ref: TM-T7398
| 1mg | 52.00 € | ||
| 5mg | 97.00 € | ||
| 10mg | 159.00 € | ||
| 25mg | 261.00 € | ||
| 50mg | 419.00 € | ||
| 100mg | 617.00 € | ||
| 1mL*10mM (DMSO) | 96.00 € |
Estimated delivery in United States, on Thursday 3 Apr 2025
ONC212
CAS:1807861-48-8
ONC212 is a potent anti-cancer agent with transcriptional regulatory activity. ONC212 has been shown to …
Formula:
C24H23F3N4O
Purity:
Min. 95%
Molecular weight:
440.46 g/mol
Ref: 3D-HXC86148
| 10mg | 817.00 € | ||
| 25mg | 1,254.00 € | ||
| 50mg | 2,005.00 € |
Estimated delivery in United States, on Thursday 8 May 2025
